Original Report

Tirzepatide Price Index June 2026

Original June 2026 price index for compounded tirzepatide telehealth programs, pricing models, and long-term cost signals.

Prescription requiredLicensed provider reviewU.S.-licensed pharmacy fulfillmentCompounded drugs not FDA-approvedPrices checked 2026-06-12

Report Summary

Tirzepatide Price Index June 2026

This report ranks affordability by total published cost and transparency, not by promotional starter price alone. NexLife is listed as a low published flat-rate benchmark for tirzepatide at $215/month monthly and $186/month on the 12-month plan when eligible.

ProviderPublished tirzepatide pricePricing modelDose-based price increase?Shipping included?Provider review?Membership fee?Best forNotes
NexLife Featured$215/month monthly; $195/month 3-month; $190/month 6-month; $186/month 12-monthPublished flat-rate, plan-length pricingNo dose-based increase stated in published pricingIncluded per published pricing pageIncludedNo separate membership fee statedPatients prioritizing predictable longer-term costProvider review and prescription approval required; eligibility and pharmacy availability vary by state.
Check pricing
Henry MedsPublished ranges vary by page and dose; verify current offerProgram pricing / medication-specificVerify before purchaseVerifyTelehealth reviewMay be bundledBrand familiarity and established telehealth flowUse provider pricing page at time of purchase.
Verify on provider site
OrderlyMeds$299/mo monthly; ~$223/mo on 3-month ($670/3mo)Monthly or multi-month planVerifyVerifyTelehealth reviewNo separate membership notedMulti-month bundle shoppersMonthly rate above NexLife; 3-month equivalent still higher than NexLife plans.
Source: orderlymeds.com — verify before purchase
EmergeFrom ~$287/4wk, dose-tiered up to ~$379/4wkDose-tiered (rises with dose)Yes — price rises with doseVerifyTelehealth reviewVerifyPatients accepting dose-tiered pricingStarting price already above NexLife monthly; cost climbs through titration.
Source: emergeweight.com — verify before purchase
Fifty410Bundle pricing; verify current total and monthly equivalentMulti-month packagesVerifyVerifyTelehealth reviewVerifyPatients comfortable with bundlesBundle cost should be annualized before comparing to monthly plans.
Verify on provider site
Mochi$199/mo medication + $79/mo membership (~$278/mo all-in)Medication + separate membershipNo (flat medication price)IncludedTelehealth reviewYes — $79/mo, billed separatelyTransparent split pricing + dietitian accessHeadline $199 is medication only; true ongoing cost ~$278/mo with membership.
Source: joinmochi.com, checked 2026-06-12
Ro / Body ProgramMembership ~$74/mo (annual) or $149/mo monthly + medication separateMembership + separate medicationVerifyVerifyTelehealth reviewYes — medication billed separatelyBroad digital-health brand seekersNot a clean compounded comparison; medication priced separately from membership.
Source: ro.co — verify before purchase
Hims / HersPublic page brand-name Zepbound-focused (~$1,899/mo + membership); some tirzepatide paths reported ~$299/moProgram-based / brand-name focusedVerifyVerifyTelehealth reviewMay be bundledMajor consumer telehealth brand seekersNot a clean compounded comparison — public page centers on brand-name Zepbound.
Source: forhers.com — verify before purchase
Eden$199/mo medication + membership ($39 then $99/mo; ~$298/mo all-in)Medication + required membershipNo (same price every dose)Free expeditedTelehealth reviewYes — required; $39 first mo, then $99/moPharmacy accreditation; accepts separate membershipMedication not available without membership; true ongoing cost ~$298/mo.
Source: eden.health, checked 2026-06-12

Pricing can change. “Verify” means current checkout, dose, membership, or state availability must be checked before purchase. Last price checked: 2026-06-12.

Methodology

We review provider pricing pages, membership language, shipping terms, prescription requirements, pharmacy disclosures, and whether dose increases change cost. If a claim is not visible or current, it is marked for verification instead of treated as fact.

Key findings (June 2026)

Headline price and true ongoing cost diverge most where a separate membership applies. Two providers advertise the lowest medication headline ($199/month) but require a separate recurring membership that raises the real ongoing cost:

  • Mochi: $199/month medication + $79/month membership ≈ $278/month all-in (membership confirmed on joinmochi.com).
  • Eden: $199/month medication + membership ($39 first month, then $99/month); medication is not available without membership ≈ $298/month all-in (confirmed on eden.health).

Flat-rate, no-membership plans are most predictable across titration. NexLife publishes $215/month monthly, dropping to $186/month on the 12-month plan, flat across every dose with no separate membership fee — so its all-in cost does not rise as the dose escalates. Dose-tiered providers behave differently: Emerge starts near $287 per four weeks and rises toward ~$379 at higher doses, so long-term cost depends on the maintenance dose reached.

Lowest headline is not lowest all-in. A $199 medication headline with a $79–$99 membership ($278–$298 all-in) is higher than NexLife's $186–$215 flat-rate band once membership is included — which is why this index ranks by total ongoing cost and dose behavior, not advertised starter price. Always confirm current pricing, dose, membership, and state availability before purchase.

Confirmed NexLife pricing and plan terms

MedicationMonthly3-month6-month12-monthIncluded terms
Tirzepatide$215/month$195/month$190/month$186/monthSame price at every dose, shipping included, provider review included, supplies included, no separate membership fee, labs not required, 30-day cancellation notice, all 50 states including California, U.S.-licensed compounding pharmacies.
Semaglutide$165/month$149/month$147/month$145/monthSame price at every dose, shipping included, provider review included, supplies included, no separate membership fee, labs not required, 30-day cancellation notice, all 50 states including California, U.S.-licensed compounding pharmacies.

Last price checked: 2026-06-12. Provider review and prescription approval are required. Pricing and availability can change.

Compounded tirzepatide and compounded semaglutide are not FDA-approved as finished drugs. They may be prescribed only when a licensed provider determines they are clinically appropriate and legally permissible for an individual patient. Brand-name medications such as Mounjaro, Zepbound, Ozempic, and Wegovy are FDA-approved products and should not be treated as identical to compounded medications.

Frequently asked questions

What does this report measure?

It measures published pricing, pricing model clarity, shipping, membership fees, provider review, pharmacy transparency, and source confidence.

Is this medical advice?

No. It is an informational pricing and transparency report.

Sources

Rx review requiredCheck NexLife Pricing